Ancora Advisors, LLC Crispr Therapeutics Ag Transaction History
Ancora Advisors, LLC
- $4.37 Billion
- Q2 2025
A detailed history of Ancora Advisors, LLC transactions in Crispr Therapeutics Ag stock. As of the latest transaction made, Ancora Advisors, LLC holds 4,166 shares of CRSP stock, worth $292,411. This represents 0.0% of its overall portfolio holdings.
Number of Shares
4,166
Previous 3,810
9.34%
Holding current value
$292,411
Previous $129,000
56.59%
% of portfolio
0.0%
Previous 0.0%
Shares
15 transactions
Others Institutions Holding CRSP
# of Institutions
532Shares Held
68.7MCall Options Held
3.67MPut Options Held
2.25M-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.2MShares$715 Million4.09% of portfolio
-
Capital International Investors Los Angeles, CA5.59MShares$393 Million0.05% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD3.68MShares$259 Million0.11% of portfolio
-
State Street Corp Boston, MA3.27MShares$230 Million0.01% of portfolio
-
Ubs Group Ag2.84MShares$200 Million0.02% of portfolio
About CRISPR Therapeutics AG
- Ticker CRSP
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 78,009,296
- Market Cap $5.48B
- Description
- CRISPR Therapeutics AG, a gene editing company, focuses on developing gene-based medicines for serious diseases using its proprietary Clustered Regularly Interspaced Short Palindromic Repeats (CRISPR)/CRISPR-associated protein 9 (Cas9) platform. Its CRISPR/Cas9 is a gene editing technology that allows for precise directed changes to genomic DNA....